InMode (INMD) Stock Forecast & Price Target
$778.57M
Market Cap
10.70
P/E
10.44
Forward P/E
61
Score
INMD price $13.53 +0.16 +1.20%
Stocklytics score rationale: value 77, quality 68, growth 37.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 23082000 | 53456000 | 100162000 | 156361000 | 206107000 | 357565000 | 454271000 | 492048000 | 394818000 | 370495000 |
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional…
Consensus Hold from 5 analysts. Average price target $19.00, +40.4% versus the current price. Low $19.00. High $19.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $19.00 for InMode (INMD), 40.4% above the current price of $13.53. Of 5 analysts covering the stock, 0 rate it Buy or Strong Buy, 5 Hold, and 0 Sell or Strong Sell, giving a consensus of Hold.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $19.00 |
|---|---|
| Average | $19.00 |
| High | $19.00 |
The average is 40.4% above the current price of $13.53.
Of 5 analysts, 0 rate InMode Buy or Strong Buy, 5 Hold, and 0 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.
Analyst averages on file: 2026, EPS $1.30, revenue $370.32 million. 2027, EPS $1.37, revenue $377.73 million.
The Stocklytics Score for INMD is 61 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$19.00 average, with a published range of $19.00 to $19.00.
The consensus is Hold from 5 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $1.30. The average revenue estimate is $370.32 million.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: InMode · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$778.57M
Market Cap
10.70
P/E
10.44
Forward P/E
61
Score